ICBLD 2020 : International Conference on Drugs for Blood Disorders is the premier interdisciplinary platform for the presentation of new advances and research results in the fields of Drugs for Blood Disorders. The conference will bring together leading academic scientists, researchers and scholars in the domain of interest from around the world. Topics of interest for submission include, but are not limited to:

• Leukemia Drugs
• Lymphoma Drugs
• Myeloma Drugs
• Leukemia Drugs
• Arranon (Nelarabine)
• Asparaginase Erwinia chrysanthemi
• Hyper-CVAD
• Arsenic Trioxide
• Cerubidine (Daunorubicin Hydrochloride)
• Cyclophosphamide
• Alemtuzumab
• Arzerra (Ofatumumab)
• Bendamustine Hydrochloride
• Bendeka (Bendamustine Hydrochloride)
• Lymphoma Drugs
• Doxorubicin
• Bleomycin
• Vinblastine
• Dacarbazine
• Bleomycin
• Etoposide
• Doxorubicin
• Cyclophosphamide
• Vincristine
• Procarbazine
• Myeloma Drugs:
• Melphalan
• Vincristine (Oncovin)
• Cyclophosphamide (Cytoxan)
• Etoposide (VP-16)
• Doxorubicin (Adriamycin)
• Liposomal doxorubicin (Doxil)
• Bendamustine (Treanda)